ロード中...
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: Data from FIRE-3 and TRIBE trials
BACKGROUND: Through enhancement of the Wnt signaling pathway R-spondins are oncogenic drivers in colorectal cancer. Experimental data suggest that the R-spondin/Wnt axis stimulates VEGF-dependent angiogenesis. We therefore hypothesize that variations within R-spondin genes predict outcome in patient...
保存先:
| 出版年: | Eur J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513926/ https://ncbi.nlm.nih.gov/pubmed/32305727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2020.02.048 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|